
Nivaquine P 50mg Suspension
Marketer
Abbott
Salt Composition
Chloroquine (50mg)
Overview Nivaquine P 50mg Suspension
Chloroquine phosphate 50mg oral suspension is an anti-parasitic medication used for malaria prophylaxis and treatment resulting from mosquito bites. It's also indicated for treating amoebic dysentery in children. Administer the suspension orally, ideally post-meal, to minimize stomach upset. Avoid concurrent antacid use within a four-hour window due to potential absorption interference. The suspension may taste slightly bitter; mixing with juice can improve palatability. If vomiting occurs shortly after administration, soothe your child and repeat the dose after 30 minutes; however, omit the dose if the next scheduled dose is imminent. Never double the dose. Dosage, frequency, and administration method should strictly adhere to your doctor's instructions, which are tailored to your child's weight, age, health status, and response to treatment. Initial doses may be higher for the first one or two days, followed by a lower maintenance dose. Consistent adherence to the prescribed regimen is crucial, as prolonged use can lead to adverse effects. Potential side effects include headache, nausea, anorexia, diarrhea, gastrointestinal discomfort, rash, pruritus, alopecia, and photosensitivity. These are usually transient; however, persistent symptoms warrant medical attention. Complete disclosure of your child's medical history, including allergies, current medications, and any pre-existing liver, kidney, neurological, cardiac, myopathic, genetic, hematological, or ophthalmological conditions, is vital for optimal treatment planning.
Uses of Nivaquine P 50mg Suspension
Managing Amoebic Infections and Malaria
Major Benefits of Nivaquine P 50mg Suspension:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Always consult the product label for complete instructions prior to consumption. Use a measuring device to accurately dispense the oral dose. Ensure thorough shaking before each use. Nivaquine P 50mg Suspension should be ingested with food.
Common Side effects of Nivaquine P 50mg Suspension:
- Upset stomach
- Photosensitivity
- Rash
- Headache
- Dizziness
- Vomiting
- Nausea
- Stomach pain
- Loss of appetite
- Diarrhea
How to use Nivaquine P 50mg Suspension:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Always consult the product label for usage instructions prior to consumption. Accurate measurement should be achieved using a measuring cup; oral administration is recommended. Ensure thorough shaking before each dose. Nivaquine P 50mg Suspension should be ingested with food.
How Nivaquine P 50mg Suspension works:
Chloroquine phosphate 50mg oral suspension combats parasitic infections, specifically malaria and amoebiasis. Its mechanism involves elevating heme concentrations and intracellular pH within infected red blood cells, disrupting parasite viability. Additionally, it directly targets the malarial parasite's DNA, resulting in parasite death and halting infection progression.
SAFETY ADVICE
KidneySAFE IF PRESCRIBED
Nivaquine P 50mg Suspension can be used safely in patients with kidney disorders; dosage modification is unnecessary. Nevertheless, extended administration could potentially affect renal function in children. Its use is contraindicated in children with severe kidney impairment.
LiverCAUTION
Patients with liver conditions should exercise caution when using Nivaquine P 50mg Suspension. Dosage modification for Nivaquine P 50mg Suspension might be necessary. Physician consultation is advised.
What if you forget to take Nivaquine P 50mg Suspension :
Remain calm. If your pediatrician hasn't instructed otherwise, administer the forgotten dose immediately upon recollection. However, omit the missed dose if the next scheduled dose is imminent. Avoid doubling the dose; adhere to the recommended medication schedule.
Facts to Know About Nivaquine P 50mg Suspension
| Label | Value |
|---|---|
| Type of Compound | 4-Aminoquinoline-based compound |
| Potential for Dependence | None. |
| Type of Treatment | Eye medication. |
| Mechanism of Action | Quinoline-based antimalarials |
